Variant report
Variant | esv3320182 |
---|---|
Chromosome Location | chr1:71487040-71489912 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:71484257..71486555-chr1:71489083..71490597,2 | MCF-7 | breast: | |
2 | chr1:71488605..71491550-chr1:71545533..71547496,2 | K562 | blood: | |
3 | chr1:71128661..71130608-chr1:71489552..71491952,2 | K562 | blood: | |
4 | chr1:71488156..71490050-chr1:71494544..71497230,2 | K562 | blood: | |
5 | chr1:71486485..71490048-chr1:71491402..71493576,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CTH-13 | chr1:71489270-71489329 | NONHSAT003876 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229956 | chromatin interactions |
ENSG00000132485 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188010976 | chr1:71487045-71487046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs9425052 | chr1:71487055-71487056 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs537261744 | chr1:71487113-71487114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2300170 | chr1:71487115-71487116 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
5 | rs570154960 | chr1:71487165-71487166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114774129 | chr1:71487203-71487204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs147554342 | chr1:71487245-71487246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572756547 | chr1:71487281-71487282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs535385249 | chr1:71487288-71487289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs191127842 | chr1:71487311-71487312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs574892228 | chr1:71487345-71487346 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs2817859 | chr1:71487362-71487363 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs2817860 | chr1:71487385-71487386 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs2300171 | chr1:71487393-71487394 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
15 | rs545464079 | chr1:71487394-71487395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2300172 | chr1:71487407-71487408 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs371753922 | chr1:71487433-71487434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35206244 | chr1:71487485-71487486 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs2300173 | chr1:71487491-71487492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
20 | rs370355985 | chr1:71487527-71487528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142079280 | chr1:71487536-71487537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs564703048 | chr1:71487544-71487545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532295655 | chr1:71487564-71487565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2300174 | chr1:71487614-71487615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373736922 | chr1:71487724-71487725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570037407 | chr1:71487758-71487759 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547646033 | chr1:71487760-71487761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs148259764 | chr1:71487767-71487768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs10749799 | chr1:71487785-71487786 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs2300175 | chr1:71487790-71487791 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs2300176 | chr1:71487812-71487813 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs569770250 | chr1:71487925-71487926 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs33929015 | chr1:71488006-71488007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs66540839 | chr1:71488007-71488008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs33936437 | chr1:71488009-71488010 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
36 | rs556814172 | chr1:71488034-71488035 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575095906 | chr1:71488054-71488055 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571845081 | chr1:71488060-71488061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537213150 | chr1:71488075-71488076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs79660813 | chr1:71488114-71488115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs576842364 | chr1:71488131-71488132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs10789316 | chr1:71488135-71488136 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs552659445 | chr1:71488161-71488162 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs192147855 | chr1:71488168-71488169 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140289064 | chr1:71488201-71488202 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs572394332 | chr1:71488210-71488211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150339843 | chr1:71488215-71488216 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116478015 | chr1:71488227-71488228 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs564355180 | chr1:71488229-71488230 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532488786 | chr1:71488250-71488251 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
abnormal development | 18461090 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cancer | 20164920 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:71481800-71501000 | Weak transcription | K562 | blood |
2 | chr1:71483800-71491400 | Weak transcription | Aorta | Aorta |
3 | chr1:71485800-71494000 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr1:71486600-71488000 | Weak transcription | Fetal Heart | heart |
5 | chr1:71486800-71487200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr1:71487000-71491200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr1:71487200-71495200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr1:71488000-71488600 | Enhancers | Fetal Heart | heart |
9 | chr1:71489600-71493800 | Weak transcription | NHDF-Ad | bronchial |